Financial Resources

Sandostatin LAR Depot

< Back To Site

Prescribing Information

Patient Support Line 1-888-669-6682, 8:30 AM–5:00 PM ET

Important Safety Information

Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, with postmarketing reports of gallstones resulting in complications (inflammation of the gallbladder, bi...

Approved Use:

Sandostatin^® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin^® (octreotide acetate) Injection has been shown to be effective and tolerated for

Long-term treatment of the severe diarrhea and f...

Patient Assistance Now Oncology

Patient Assistance Now Oncology Graphic

Program overview

Novartis Oncology is committed to helping you get the Novartis medicine(s) you need. Access to medicine(s) can sometimes be difficult or confusing. PANO offers resources and support designed specifically to help make that process easier.*

PANO can offer the following services:

Help with understanding your insurance coverage and financial responsibilities throughout the insurance verification process
Aid with identifying the pharmacies covered by your insurance plan
Insurance and Medicare education
Information about financial assistance that may be available*
Patient Support Counselors who are able to provide information in more than 160 languages
One single point of contact to help guide you through getting access to the Novartis medicine(s) prescribed by your doctor

*Novartis Pharmaceuticals Corporation does not guarantee success in obtaining reimbursement or financial assistance. Third‑party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved.

To learn more, call 1-800-282-7630 or visit Patient.NovartisOncology.com.

How to Enroll

To enroll in the Sandostatin LAR Depot co-pay program, please visit Copay.NovartisOncology.com and download a co-pay card and claim form. For each subsequent injection of Sandostatin LAR Depot, a blank claim form can be downloaded by clicking below and then can be submitted with an explanation of benefits and a copy of your insurance card.

The program will issue a 16-digit virtual debit card number for you to use to pay for your out-of-pocket Sandostatin LAR Depot co-pay expenses. You may authorize your physician’s office to submit the necessary claim information on your behalf, to receive and retain the 16-digit virtual debit card number, and to process payments on your behalf. You may also submit claims independently and maintain sole ownership of the 16-digit virtual debit card number.

Download claim form

Universal Co-pay Program

You may be eligible for immediate co-pay savings on your next prescription of Sandostatin^® LAR Depot (octreotide acetate) for injectable suspension.

Eligible patients with private insurance may pay $25 per month
Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*

* Limitations apply. This offer is only available to patients with private insurance. The program is not available for patients who are enrolled in Medicare, Medicaid, or any other federal or state health care program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1‑877‑577‑7756.

To find out if you are eligible for the Universal Co-pay Program, call 1-877-577-7756 or visit Copay.NovartisOncology.com.

See if you're eligible

Next: RealSupport™